COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01449344
Brief Title: Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL ((R-HAD))

First Submitted : September 28, 2011
First Submitted that Met QC Criteria : October 7, 2011
First Posted : October 10, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : March 6, 2017
Last Update Posted : March 7, 2017